YCBD Financials

Income Statement
MetricQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025
Revenue
5.6M
-1.5%
5.6M
+12.4%
5.0M
+6.3%
4.7M
+2.5%
4.6M
Cost of Revenue
2.5M
+5.6%
2.4M
+18.2%
2.0M
+3.7%
1.9M
+9.5%
1.8M
Gross Profit
3.0M
-6.7%
3.3M
+8.5%
3.0M
+8.1%
2.8M
-1.9%
2.8M
Operating Expenses
4.2M
+2.7%
4.1M
+23.4%
3.3M
-5.1%
3.5M
-7.3%
3.7M
R&D
0
0
0
0
0
SG&A
0
0
0
0
0
Operating Income
-1130477
-41.2%
-800784
-179.7%
-286288
+58.3%
-685816
+24.2%
-904686
EBITDA
-871508
-58.7%
-549234
-1244.6%
-40846
+90.4%
-423751
+32.1%
-624513
Net Income
-1127202
-41.3%
-797978
-181.8%
-283131
+58.4%
-679968
+24.0%
-895272
EPS (Basic)
$-0.11
-37.5%
$-0.08
-100.0%
$-0.04
+50.0%
$-0.08
+61.9%
$-0.21
EPS (Diluted)
$-0.11
-37.5%
$-0.08
-100.0%
$-0.04
+50.0%
$-0.08
+61.9%
$-0.21
Shares (Diluted)
10.6M
+1.7%
10.4M
+16.0%
9.0M
+0.5%
9.0M
+54.9%
5.8M
cbdMD (YCBD) โ€” Financials